Enhancing Solubility via Formulation Development
Total Trials
2
As Lead Sponsor
0
As Collaborator
Total Enrollment
57
NCT04846036
The KHENERGYC Study
Phase: Phase 2
Role: Collaborator
Start: Feb 1, 2021
Completion: Dec 1, 2025
NCT07064564
BIOPIN 101b: Pharmacokinetics and Safety Study of Low- and High-Dose Naltrexone Implants vs Monthly Vivitrol in Healthy Volunteers
Phase: Phase 1
Start: Feb 1, 2026
Completion: Jul 1, 2027
Loading map...